This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Molina Healthcare (MOH) Q2 Earnings Beat Estimates, Rise Y/Y
by Zacks Equity Research
Molina Healthcare's (MOH) second-quarter earnings trump estimates on the back of lower expenses and the Meridian buyout.
WellCare Health (WCG) Q2 Earnings & Revenues Beat, Rise Y/Y
by Zacks Equity Research
WellCare Health's (WCG) second-quarter earnings gain from improved revenues and higher membership.
Magellan Health (MGLN) Q2 Earnings Beat Estimates, Down YoY
by Zacks Equity Research
Magellan Healths (MGLN) Q2 earnings reflect a pickup in its business, which should aid its performance in the second half.
HCA Healthcare (HCA) Q2 Earnings and Revenues Lag Estimates
by Zacks Equity Research
HCA Healthcare's (HCA) second-quarter earnings decline due to escalating expenses.
Universal Health's (UHS) Q2 Earnings Top Estimates, Rise Y/Y
by Zacks Equity Research
Universal Health's (UHS) second-quarter results gain from its healthy top-line growth.
Dow 30 Stock Roundup: Impressive INTC, MMM, V, UTX Earnings, BA, CAT Disappoint
by Swarup Gupta
The Dow started the week on a high note but trended lower as lackluster earnings numbers flowed in.
The Zacks Analyst Blog Highlights: UnitedHealth, Citigroup, Honeywell, IBM and Amgen
by Zacks Equity Research
The Zacks Analyst Blog Highlights: UnitedHealth, Citigroup, Honeywell, IBM and Amgen
Should First Trust Capital Strength ETF (FTCS) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for FTCS
How to Win on Stocks with a Trade War
by John Blank
Yes, tariffs slow growth. And yes, rate cuts help stocks.
Stock Market News For Jul 22, 2019
by Zacks Equity Research
Markets closed lower on Friday after a report stated that Fed officials would reduce the benchmark interest rates in its next meeting by only a quarter percentage points.
Top Analyst Reports for UnitedHealth, Citigroup & Honeywell
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including UnitedHealth (UNH), Citigroup (C) and Honeywell (HON).
Healthcare ETFs in Focus on UnitedHealth's Q2 Earnings
by Sweta Killa
ETFs having the largest allocation to this health insurance giant are in focus post Q2 earnings.
Strong Economic Data
by Zacks Equity Research
Strong Economic Data
Jobless Claims, Philly Fed Strong; Plus Q2: MS, UNH & More
by Mark Vickery
Initial Jobless Claims stayed within a favorable range while Philly Fed posted a big improvement. Plus more Q2 earnings data.
UnitedHealth (UNH) Beats on Q2 Earnings, Guides Up for 2019
by Zacks Equity Research
Strong segment performance, membership growth and cost control aid UnitedHealth's (UNH) Q2 results.
UnitedHealth Group (UNH) Beats Q2 Earnings Estimates
by Zacks Equity Research
UnitedHealth (UNH) delivered earnings and revenue surprises of 4.05% and -0.12%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?
The 5 Hottest Earnings Charts This Week
by Tracey Ryniec
The 5 stocks have had the sizzle over the last 5 years. Will it continue this week?
The Zacks Analyst Blog Highlights: JP Morgan, UnitedHealth, Lockheed Martin and BHP Billiton
by Zacks Equity Research
The Zacks Analyst Blog Highlights: JP Morgan, UnitedHealth, Lockheed Martin and BHP Billiton
UnitedHealth (UNH) to Report Q2 Earnings: What's in Store?
by Zacks Equity Research
UnitedHealth's (UNH) second-quarter results are expected to be boosted by the revenue growth at UnitedHealthcare and Optum segments and increasing membership.
Dow ETF Appears Strong Ahead of Q2 Earnings
by Sweta Killa
With most blue-chip companies' earnings scheduled over the coming weeks and investors' sentiment being mixed, investors should closely monitor the movement of the Dow ETF.
New Earnings Season Opens: Global Week Ahead
by John Blank
The dominant trader focus inside the Global Week Ahead will surely be the Q2 earnings season -- with the usual early focus upon Financials.
The Zacks Analyst Blog Highlights: Microsoft, UnitedHealth, Costco, Uber and Microchip Technology
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Microsoft, UnitedHealth, Costco, Uber and Microchip Technology
Is UnitedHealth Group (UNH) Outperforming Other Medical Stocks This Year?
by Zacks Equity Research
Is (UNH) Outperforming Other Medical Stocks This Year?
Cigna Stock Gains Near 9% on Drug Rebate Proposal Pullback
by Zacks Equity Research
Cigna's (CI) Pharmacy Benefits management is poised to gain due to the pullback of the drug rebate proposal.
Is UnitedHealth (UNH) Stock a Buy Heading into Q2 2019 Earnings?
by Benjamin Rains
Shares of UnitedHealth Group (UNH) popped Friday after they surged Thursday to help spur the Dow Jones Industrial Average's rally. But should investors consider buying UNH stock ahead of its Q2 earnings results?